Azine-carboxamides as anticancer agents

Expert Opinion on Therapeutic Patents

Volumn 16, Issue 8, 2006, Pages 1175-1178

  Hölzemann, Günter ^a  

^a MERCK KGAA   (Germany)

Author keywords

B Raf; Bisamide; Carboxylic acid; Kinase inhibitor; m phenylendiamine; Pyrimidine

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATIC CARBOXYLIC ACID; AZINE CARBOXAMIDE; B RAF KINASE; CARBOXYLIC ACID; DIAMIDE; L 779450; MORPHOLINE DERIVATIVE; N [5 (3 DIMETHYLAMINOBENZAMIDO) 2 METHYLPHENYL] 4 HYDROXYBENZAMIDE; PHENYLENEDIAMINE DERIVATIVE; PIPERIDINE DERIVATIVE; PROTEIN INHIBITOR; PYRAZINE; PYRIDINE; PYRIMIDINE; PYRIMIDINE DERIVATIVE; QUINAZOLINONE DERIVATIVE; RAF PROTEIN; SB 590885; SORAFENIB; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL BOND; DRUG PROTEIN BINDING; DRUG SELECTIVITY; DRUG SOLUBILITY; ENZYME ACTIVITY; GENE MUTATION; LIPOPHILICITY; STRUCTURE ACTIVITY RELATION;

EID: 33747081611     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.16.8.1175     Document Type: Article

References (9)

1. DIBB NJ, DILWORTH SM, MOL CD: Switching on kinases: oncogenic activation of BRAF and the PDGFR family. Nature Rev. (2004) 4:718-727.
2. DAVIES H, BIGNELL GR, COX C et al.: Mutations of the BRAF gene in human cancer. Nature (2002) 417:949-954.
3. STRUMBERG D, SEEBER S: Raf kinase inhibitors in Oncology. Onkologie (2005) 28:101-107.
4. THOMPSON N, LYONS J: Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery. Curr. Opin. Pharm. (2005) 5(4):350-356.
5. HALL-JACKSON CA, EYERS PA, COHEN P et al.: Paradoxical activation of Raf by a novel Raf inhibitor. Chem. Biol. (1999) 6:559-568.
6. TAKLE AK, BROWN MJB, DAVIES S et al.: The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. Bioorg. Med. Chem. Lett. (2006) 16:378-381.
7. RINI BI: Sorafenib. Expert Opin. Pharmacother. (2006) 7(4):453-461.
8. BEERAM M, PATNAIK A, ROWINSKY EK: Raf: a strategic target for therapeutic development against cancer. J. Clin. Oncol. (2005) 23:6771-6790.
9. BROWN DS, BELFIELD AJ, BROWN GR et al.: A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis. Bioorg. Med. Chem. Lett. (2004) 14:5383-5387.